These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 5479858)
1. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride. Baker BR; Ashton WT J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858 [No Abstract] [Full Text] [Related]
2. Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride. Baker BR; Ashton WT J Med Chem; 1970 Nov; 13(6):1161-5. PubMed ID: 5479857 [No Abstract] [Full Text] [Related]
3. Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluoride. Baker BR; Ashton WT J Med Chem; 1970 Nov; 13(6):1149-54. PubMed ID: 5479855 [No Abstract] [Full Text] [Related]
4. Irreversible enzyme inhibitors. CLXXVII. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. II. Baker BR; Vermeulen NM J Med Chem; 1970 Nov; 13(6):1154-60. PubMed ID: 5479856 [No Abstract] [Full Text] [Related]
5. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II. Baker BR; Lourens GJ J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173 [No Abstract] [Full Text] [Related]
6. Irreversible enzyme inhibitors. 196. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine and bearing a terminal phenyl sulfonate group. Baker BR; Ashton WT J Med Chem; 1972 Sep; 15(9):945-7. PubMed ID: 5051014 [No Abstract] [Full Text] [Related]
7. Irreversible enzyme inhibitors. CLX. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. Baker BR; Janson EE; Vermeulen NM J Med Chem; 1969 Sep; 12(5):898-902. PubMed ID: 5812208 [No Abstract] [Full Text] [Related]
8. Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity. Baker BR; Lourens GJ J Med Chem; 1969 Jan; 12(1):92-4. PubMed ID: 5763049 [No Abstract] [Full Text] [Related]
9. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV. Baker BR; Lourens GJ J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172 [No Abstract] [Full Text] [Related]
10. Irreversible enzyme inhibitors. CLV. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[4-(omega-aminoalkoxy)-3-chlorophenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines bearing a terminal sulfonyl fluoride. Baker BR; Janson EE J Med Chem; 1969 Jul; 12(4):672-6. PubMed ID: 5793160 [No Abstract] [Full Text] [Related]